Meet Grove. Your AI growth strategist. Get a free diagnosis in 4 minutes.
Try Grove Free
Transparent Growth Measurement (NPS)

Oncology and Cancer Hospital Marketing Built for the Second-Opinion Journey

A cancer diagnosis starts the longest consideration window in healthcare. Families contact 3 or 4 institutions over several weeks, and the one that wins is rarely the one contacted first. upGrowth builds oncology acquisition around that window instead of against it: named sub-specialty visibility, records-review turnaround, and the logistics answers that decide out-of-state and international enquiries.

What Actually Decides an Oncology Case

The Consideration Window Runs for Weeks

Families research, compare and consult across 3 or 4 institutions before committing. Campaigns optimised for same-session conversion measure almost none of that, and cost per lead improves while cases are lost.

The Reader Is Rarely the Patient

An adult child, a spouse or a referring physician is usually the one comparing institutions. Content written to reassure a patient often fails the person actually making the shortlist.

Response Time Beats Message

The institution that returns a records review quickly, with a named clinician attached, tends to win. That is an operational commitment, not a creative one, and it sits outside the scope of most marketing engagements.

Cross-Border Enquiries Die on Logistics

International and out-of-state families abandon over visas, travel, accommodation, duration of stay and who coordinates it. These questions are unanswered on most oncology websites, so the enquiry ends before clinical capability is ever assessed.

How We Build Oncology Visibility

Oncology rewards named clinical authority far more than institutional brand. A sub-specialist with a visible, attributable body of work is easier for both a family and an answer engine to evaluate than a hospital name alone.

  • 01Sub-Specialty Clinician Visibility

    We build discoverable, attributable profiles for named oncologists by sub-specialty, because that is the level at which second-opinion searches actually happen. upGrowth works with Dr. Aditya Sarin, medical oncologist at Sir Ganga Ram Hospital, New Delhi, on exactly this.

  • 02Second-Opinion Journey Content

    Content mapped to the real sequence a family moves through: what a second opinion involves, what records are needed, how long a review takes, and what happens next. Practical, not promotional.

  • 03Generative Engine Optimisation

    Health queries attract the strictest source selection of any category in AI answers. We build the attribution, sourcing and entity signals that make an oncology programme quotable rather than skipped.

  • 04International Patient Logistics Content

    Visa guidance, travel and stay duration, coordinator contact and cost structure, published rather than promised on a call. This is where cross-border enquiries are won or lost.

  • 05Referral Pathway Marketing

    Referring physicians are an audience with their own evaluation criteria, their own channels and their own timeline. We treat them as a distinct acquisition motion rather than a relationship exercise.

  • 06Enquiry-to-Consult Instrumentation

    Timestamps from enquiry received to records requested, records received to clinician response, and response to consultation booked. Without these the funnel is unmeasurable past the form.

Four stage diagram of the oncology second-opinion window: diagnosis, enquiry, named clinician response, consultation attended, measured as cost per consultation attended
Contact Us

Built Around Weeks, Not Sessions

Most healthcare marketing assumes a decision that resolves in one visit. Oncology does not. The patient may never be the person reading your website, the enquiry often arrives from another state or another country, and the deciding factor is usually how fast a named clinician responds to a records review rather than anything in your campaign. We plan oncology acquisition as a multi-week, multi-person decision with a defined owner at every step.

What We Run for Oncology Programmes

Search and Content

Sub-specialty search visibility and second-opinion journey content built for a researching family.

Generative Engine Optimisation

Presence inside AI-generated answers, where an increasing share of health research now begins.

Clinician Authority Building

Named, attributable expertise for individual oncologists across owned and third-party surfaces.

International Patient Acquisition

Logistics-first content and enquiry handling for cross-border and out-of-state families.

Referral Pathway Programmes

A distinct motion aimed at referring physicians, with its own funnel and reporting.

Funnel Instrumentation

Measurement from enquiry to records to clinician response to consultation, replacing cost per lead.

Read the healthcare growth series: 13 episodes on what breaks between an enquiry and an appointment ↗

Related Healthcare Specialties

Our Roster Of Thriving, Happy Clients

Constraints Specific to Oncology Marketing

Outcome Claims Are Off Limits

Survival figures, success rates and comparative efficacy cannot be used in marketing. Any oncology strategy that depends on outcome claims is unworkable before it starts, and the strongest programmes are built on process transparency instead.

Testimonials Carry Real Exposure

Patient testimonials in oncology are both regulated and ethically fraught. We build credibility through named clinical expertise and published process rather than through patient stories.

Ad Platforms Restrict the Category

Health targeting restrictions limit audience building and remarketing. Platform policy changes without notice, so current policy must be checked directly before any campaign, and channel concentration is a business risk.

Cost Per Lead Hides the Failure

An oncology enquiry that never becomes a consultation still counts as a lead. Reporting that stops at the form will show improvement while the department loses cases.

Why upGrowth for Oncology

We work with oncology clinicians and healthcare organisations on visibility, patient acquisition and AI search presence. Our work in this specialty is built on making named clinical expertise legible and attributable rather than on claims we are not permitted to make.

We Plan for the Actual Decision Window

Acquisition designed for a decision that runs weeks and involves several people, with measurement that survives past the first touch.

Named Clinician Authority, Built Properly

We work with individual oncologists on discoverable, attributable expertise. upGrowth’s work with Dr. Aditya Sarin is built on that principle.

Cross-Border Experience

We run India patient acquisition for HELENE Clinic, Tokyo, so the international enquiry path is something we work on directly rather than theoretically.

AI Search Is a Standing Practice

Generative engine optimisation runs as a named service here, not as an add-on to search. Health carries the strictest source selection of any category in AI answers, so the sourcing, attribution and entity work has to be deliberate to be quoted at all.

Why Oncology Marketing Fails Differently

The metric is the problem. Oncology is judged on cost per lead in most hospitals, and cost per lead cannot see a decision that takes 3 weeks and involves 4 institutions. A department can report improving lead costs across a quarter in which it lost every case it competed for.

The metric that works is cost per consultation attended, split by enquiry origin, with the time from records received to named clinician response reported alongside it. That second number is usually the one that moves the outcome, and it is almost never on a marketing dashboard because it belongs to operations.

Our series on healthcare growth covers the mechanism in detail in Pain in the Diagnosis.

Testimonials

Web Stories

View More
Contact Us